Study Stopped
Logistical problmens, collisions with other studies
New Methods for Early Detection of Acute Kidney Injury After Heart Surgery
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
The investigators intend to study 2 new methods for the early detection of Acute Kidney Injury (AKI) after cardiac surgery and compare and combine the predictive abilities of these methods with established renal injury markers and epidemiological models to detect (AKI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2019
CompletedFirst Posted
Study publicly available on registry
June 4, 2019
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedSeptember 3, 2025
August 1, 2025
8 months
June 2, 2019
August 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acute Kidney Injury
Acute Kidney Injury defined by KDiGO criteria
48 hours
Secondary Outcomes (1)
30 day Mortality
30 days
Study Arms (2)
Acute kidney injury, no acute kidney injury
Acute kidney injury after cardiac surgery will be defined by KDIGO criteria, Creatinine rise from baseline and or urine production.
No Acute Kidney Injury
No Acute kidney Injury after Cardiac surgery, according to KDIGO AKI definition
Eligibility Criteria
Elective cardiac surgery patients undergoing surgery at Karolinska University Hospital, Sweden. Patients with high risk for AKI as identified by the Clevland Clinic acute renal failure score will be identified.
You may qualify if:
- years and older
- Undergoing elective cardiac surgery (Coronary artery bypass grafting, valve surgery, aortic surgery or a combination).
- Able to understand and give written consent to partake in the study
You may not qualify if:
- Unable to give consent
- Previously received a renal transplant
- Renal failure requiring dialysis prior to surgery
- Persistent atrial fibrillation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-84. doi: 10.1159/000339789. Epub 2012 Aug 7. No abstract available.
PMID: 22890468BACKGROUNDLe Dorze M, Bougle A, Deruddre S, Duranteau J. Renal Doppler ultrasound: a new tool to assess renal perfusion in critical illness. Shock. 2012 Apr;37(4):360-5. doi: 10.1097/SHK.0b013e3182467156.
PMID: 22258233BACKGROUNDRyden L, Ahnve S, Bell M, Hammar N, Ivert T, Sartipy U, Holzmann MJ. Acute kidney injury after coronary artery bypass grafting and long-term risk of myocardial infarction and death. Int J Cardiol. 2014 Mar 1;172(1):190-5. doi: 10.1016/j.ijcard.2014.01.013. Epub 2014 Jan 22.
PMID: 24502882BACKGROUNDHertzberg D, Ceder SL, Sartipy U, Lund K, Holzmann MJ. Preoperative Renal Resistive Index Predicts Risk of Acute Kidney Injury in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2017 Jun;31(3):847-852. doi: 10.1053/j.jvca.2016.10.006. Epub 2016 Oct 11.
PMID: 28017677BACKGROUNDRyden LC, Sartipy U, Holzmann MJ. Acute Kidney Injury After Surgical AVR and Long-Term Risk of Death and End-Stage Renal Disease. J Am Coll Cardiol. 2015 Nov 17;66(20):2263-2264. doi: 10.1016/j.jacc.2015.08.883. No abstract available.
PMID: 26553408BACKGROUND
Biospecimen
Blood and Urine samples will be obtained. The following biomarkers will be measured NGAL, TIMP-2, IGFBP7, KIM-1, IL-18, L-FABP, cystatin C och angiotensinogen. Renal function markers Creatinine and urea will also be measured.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Max Bell, MD, PHD
Karolinska Institutet
- STUDY DIRECTOR
Daniel Hertberg, MD, PHD
Karolinska Institutet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 2, 2019
First Posted
June 4, 2019
Study Start
January 1, 2025
Primary Completion
September 1, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
September 3, 2025
Record last verified: 2025-08